Home

The Korea Herald

Latest news

Most Popular

  1. 1

    Suneung for all: Opportunity, redemption and the right to dream

    Suneung for all: Opportunity, redemption and the right to dream
  2. 2

    [Herald Interview] 'Korea, don't repeat Hong Kong's mistakes on foreign caregivers'

    [Herald Interview] 'Korea, don't repeat Hong Kong's mistakes on foreign caregivers'
  3. 3

    [KH Explains] Why Yoon golfing is so controversial

    [KH Explains] Why Yoon golfing is so controversial
  4. 4

    Samsung stocks fall to 4-year low

    Samsung stocks fall to 4-year low
  5. 5

    Govt. cracks down on wedding industry

    Govt. cracks down on wedding industry
  1. 6

    Korean model admits drug use, seeks help from embassy in Manila: report

    Korean model admits drug use, seeks help from embassy in Manila: report
  2. 7

    NewJeans sets 14-day deadline for Ador to meet demands, including return of Min Hee-jin

    NewJeans sets 14-day deadline for Ador to meet demands, including return of Min Hee-jin
  3. 8

    Will Samsung team up with foundry rival TSMC?

    Will Samsung team up with foundry rival TSMC?
  4. 9

    Korea to take action if currency falls more

    Korea to take action if currency falls more
  5. 10

    Suneung retakes hit record amid med school expansion

    Suneung retakes hit record amid med school expansion
소아쌤

Multinational drug firms top list of approvals for clinical trials

By Paige Shin

Published : July 3, 2017 - 11:32

    • Link copied

Multinational pharmaceutical companies have topped the list in winning approvals from South Korea's drug regulatory agency for clinical trials this year, data showed Monday.

According to the data by the Ministry of Food and Drug Safety, four major global drug manufacturers have won a combined 42 clinical trials during the first half of 2017.


(Yonhap) (Yonhap)


Gilead Sciences Korea, the local unit of Gilead Sciences, won the approval of 13 clinical trials, followed by Novatis Korea with 11, Roche Korea with nine and MSD Korea with nine.

Industry officials attributed the global firms winning most of clinical trials to weaker research and development spending by local players.

Two drug firms -- Hanmi Pharmaceutical and Chong Kun Dang Pharmaceutical -- were the only two local South Korean companies topping the list by winning seven clinical trials each in the January-June period, the latest data showed. (Yonhap)

More from Headlines